Chinese Journal of Dermatology ›› 2020, Vol. 53 ›› Issue (5): 387-390.doi: 10.35541/cjd.20190199
• Reviews • Previous Articles Next Articles
Cheng Yuxin, Li Sai, Su Xiaohong
Received:
2019-01-07
Revised:
2019-06-20
Online:
2020-05-15
Published:
2020-04-30
Contact:
Su Xiaohong
E-mail:suxh@ncstdlc.org
Supported by:
Cheng Yuxin, Li Sai, Su Xiaohong. European, Australian and British guidelines for the diagnosis and treatment of Mycoplasma genitalium infections: explanation and comparison[J]. Chinese Journal of Dermatology, 2020, 53(5): 387-390.doi:10.35541/cjd.20190199
[1] | Horner PJ, Martin DH. Mycoplasma genitalium infection in Men[J]. J Infect Dis, 2017,216(suppl_2):S396⁃S405. doi: 10.1093/infdis/jix145. |
[2] | Lis R, Rowhani⁃Rahbar A, Manhart LE. Mycoplasma genitalium infection and female reproductive tract disease: a meta⁃analysis[J]. Clin Infect Dis, 2015,61(3):418⁃426. doi: 10.1093/cid/civ312. |
[3] | 苏晓红. 生殖支原体感染诊断和治疗面临的挑战[J]. 中华皮肤科杂志, 2018,51(5):328⁃331. doi: 10.3760/cma.j.issn.0412⁃4030.2018.05.002. |
[4] | Li Y, Su X, Le W, et al. Mycoplasma genitalium in symptomatic male urethritis: macrolide use is associated with increased resistance[J/OL]. Clin Infect Dis, 2019.[2019⁃06⁃18]. https://academic.oup.com/cid/advance⁃article/doi/10.1093/cid/ciz294/5440986. doi: 10.1093/cid/ciz294. |
[5] | Manhart LE, Gillespie CW, Lowens MS, et al. Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: a randomized controlled trial[J]. Clin Infect Dis, 2013,56(7):934⁃942. doi: 10.1093/cid/cis1022. |
[6] | Sethi S, Zaman K, Jain N. Mycoplasma genitalium infections: current treatment options and resistance issues[J]. Infect Drug Resist, 2017,10:283⁃292. doi: 10.2147/IDR.S105469. |
[7] | Murray GL, Bradshaw CS, Bissessor M, et al. Increasing macrolide and fluoroquinolone resistance in Mycoplasma genitalium[J]. Emerg Infect Dis, 2017,23(5):809⁃812. doi: 10.3201/eid2305.161745. |
[8] | British Association for Sexual Health and HIV. BASHH launches new NICE accredited guidelines to help prevent Mycoplasma genitalium becoming the next superbug, but funding cuts may hinder implementation[EB/OL]. (2018⁃07⁃13) [2018⁃11⁃20]. https://bashh.org/news/news/bashh⁃launches⁃new⁃nice⁃accredited⁃guidelines⁃to⁃help⁃prevent⁃mycoplasma⁃genitalium⁃becoming⁃the⁃next⁃superbug⁃but⁃funding⁃cuts⁃may⁃hinder⁃implementation/. |
[9] | Jensen JS, Cusini M, Gomberg M, et al. 2016 European guideline on Mycoplasma genitalium infections[J]. J Eur Acad Dermatol Venereol, 2016,30(10):1650⁃1656. doi: 10.1111/jdv.13849. |
[10] | ASHA. Australian STI management guidelines for use in primary care[EB/OL]. (2018⁃03) [2018.11.20]. http://www.sti.guidelines.org.au/sexually⁃transmissible⁃infections/mycoplasma⁃genitalium. |
[11] | Soni S, Horner P, Rayment M, et al. British Association for Sexual Health and HIV national guideline for the management of infection with Mycoplasma genitalium (2018)[J]. Int J STD AIDS, 2019,956462419825948. doi: 10.1177/09564624198259 48. |
[12] | Golden MR, Workowski KA, Bolan G. Developing a public health response to Mycoplasma genitalium[J]. J Infect Dis, 2017,216(suppl_2):S420⁃S426. doi: 10.1093/infdis/jix200. |
[13] | Bradshaw CS, Jensen JS, Waites KB. New horizons in Mycoplasma genitalium treatment[J]. J Infect Dis, 2017,216(suppl_2):S412⁃S419. doi: 10.1093/infdis/jix132. |
[14] | Couldwell DL, Jalocon D, Power M, et al. Mycoplasma genitalium: high prevalence of resistance to macrolides and frequent anorectal infection in men who have sex with men in western Sydney[J]. Sex Transm Infect, 2018,94(6):406⁃410. doi: 10.1136/sextrans⁃2017⁃053480. |
[15] | The U.S. Food and Drug Administration. FDA permits marketing of first test to aid in the diagnosis of a sexually⁃transmitted infection known as Mycoplasma genitalium [EB/OL].(2019⁃01⁃23) [2019⁃06⁃18]. https://www.fda.gov/news⁃events/press⁃announcements/fda⁃permits⁃marketing⁃first⁃test⁃aid⁃diagnosis⁃sexually⁃transmitted⁃infection⁃known⁃mycoplasma. |
[16] | TRH R, Fairley CK, Murray GL, et al. Outcomes of resistance⁃guided sequential treatment of Mycoplasma genitalium infections: a prospective evaluation[J]. Clin Infect Dis, 2019,68(4):554⁃560. doi: 10.1093/cid/ciy477. |
[17] | Lund M, Pasternak B, Davidsen RB, et al. Use of macrolides in mother and child and risk of infantile hypertrophic pyloric stenosis: nationwide cohort study[J]. BMJ, 2014,348:g1908. doi: 10.1136/bmj.g1908. |
[18] | Falk L, Enger M, Jensen JS. Time to eradication of Mycoplasma genitalium after antibiotic treatment in men and women[J]. J Antimicrob Chemother, 2015,70(11):3134⁃3140. doi: 10.1093/jac/dkv246. |
[1] | Lei Jiehao, Hong Weisong, Lin Fuquan, Hu Wenting, Xu Ai′e. In vitro culture of melanocytes from segmental vitiligo-like nevus depigmentosus lesions and its clinical significance [J]. Chinese Journal of Dermatology, 2022, 55(9): 798-802. |
[2] | Lyu Sha, Wang Shuang, Wu Hanfei, Zhang Mingrui, Hu Xin, Li Fuqiu. Research progress in sporotrichosis [J]. Chinese Journal of Dermatology, 2022, 55(7): 629-632. |
[3] | Gao Zirui, Zhao Pei, Dou Yuanqing, Liu Ping, Zhang Jianzhong. Efficacy and safety of dupilumab in the treatment of adult prurigo nodularis [J]. Chinese Journal of Dermatology, 2022, 55(7): 562-565. |
[4] | Wang Lingyan, Pan Jing, Miao Gang, Chang Xiaodan, Jin Qiuzi, Guo Ningning, Zhang Jiayu. Analysis of difficult-to-treat sites in patients with psoriasis who received biological therapy [J]. Chinese Journal of Dermatology, 2022, 55(7): 583-587. |
[5] | Huang Xin, Chen Xiaoyun, Li Yaping, Liang Xingkun, Zhang Guiying, Zhou Ying, Zhan Yi, Luo Shuaihantian, Liao Jieyue, Xiao Rong, Long Hai. Efficacy and safety of dupilumab in the treatment of 123 cases of atopic dermatitis [J]. Chinese Journal of Dermatology, 2022, 55(6): 486-493. |
[6] | Hu Yebei, Song Xiuzu. Tranexamic acid for the treatment of melasma [J]. Chinese Journal of Dermatology, 2022, 55(5): 460-462. |
[7] | Centre for Urticaria Research, Chinese Society of Dermatology. Guidelines for education of patients with chronic urticaria [J]. Chinese Journal of Dermatology, 2022, 0(4): 20220305-e20220305. |
[8] | Cao Hua, Zheng Jie . Evolution of diagnostic criteria for clinically amyopathic dermatomyositis [J]. Chinese Journal of Dermatology, 2022, 0(4): 20220005-e20220005. |
[9] | Luo Shuaihantian, Long Hai, Lu Qianjin, . Research advances in systemic lupus erythematosus in 2021 [J]. Chinese Journal of Dermatology, 2022, 55(4): 369-372. |
[10] | Li Yan, Li Ming, Xu Wei, Li Linfeng. Calcium-based antimicrobial peptide compounds cooling gel for the treatment of atopic dermatitis: a randomized, double-blind controlled clinical study [J]. Chinese Journal of Dermatology, 2022, 55(4): 345-348. |
[11] | Liu Bo, Song Xiaoting, Liao Shuanglu, Yu Miao, Luan Tingting, Li Ruoyu, Zhao Zuotao. Efficacy and safety of baricitinib in the treatment of moderate-to-severe atopic dermatitis: a clinical observation [J]. Chinese Journal of Dermatology, 2022, 55(4): 304-307. |
[12] | Li Hao, Wang Li, Han Xianwei, Sun Tong, Su Fang, Sun Xiaodong, Han Ying, Yang Guoling, Liu Xiaoming, Wang Kaibo. Analysis of clinical characteristics of bullous pemphigoid developing after the treatment with dipeptidyl peptidase-Ⅳ inhibitors in 32 patients with diabetes mellitus [J]. Chinese Journal of Dermatology, 2022, 55(3): 213-218. |
[13] | Writing committee expert group on “diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement”. Diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement (2022) [J]. Chinese Journal of Dermatology, 2022, 55(3): 187-195. |
[14] | Wang Juanjuan, Chen Rong, Ji Jiang, Su Wenxing, Wei Yuqian, Zhao Ying, Yin Xingping, Su Yuhua, Shi Xin. Retrospective analysis of 67 cases of neurosyphilis with abnormal mental behaviors as the initial symptom [J]. Chinese Journal of Dermatology, 2022, 55(3): 231-234. |
[15] | Li Suo, Xiang Ruiyu, Li Zhiliang, Jing Ke, Wang Yuan, Zhang Hanmei, Feng Suying. Evaluation of the value of indirect immunofluorescence on salt-split skin in the diagnosis of bullous pemphigoid [J]. Chinese Journal of Dermatology, 2022, 55(3): 235-237. |
|